Aandeel FPMI FLUOROPHARMA MEDICAL, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen FluoroPharma Medical, Inc.

Aandelen

FPMI

US3438701019

Beurs gesloten - OTC Markets
Andere beurzen
 17:35:55 26-02-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,0001 USD -50,00% Intraday-grafiek van FluoroPharma Medical, Inc. -.--% -.--%
2022 FluoroPharma Medical, Inc. Kondigt wijzigingen in de directie aan CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
FluoroPharma Medical, Inc. Announces Executive Changes
FluoroPharma Medical, Inc. Appoints Frank I Igwealor as CFO
FLUOROPHARMA MEDICAL, INC. : Changes in Control or Registrant, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
FluoroPharma Medical, Inc. Restructures CardioPET License With Massachusetts General Hospital
FluoroPharma Medical, Inc. cancelled the acquisition of Ground Fluor Pharmaceuticals, Inc.
FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt
FluoroPharma Medical, Inc. Announces Resignation of Lawrence Atinsky as Director and Member of Audit Committee and Compensation Committee of the Board of Directors
FluoroPharma Medical, Inc. Borrows $50,000 in the Form of Promissory Note; Announces Board Resignations, Effective January 1, 2017
FluoroPharma Medical, Inc. announced that it has received $0.57 million in funding
FluoroPharma Medical Inc. and Royal Philips Collaborate on Image Management for CardioPET Phase II Clinical Trial
FluoroPharma Medical, Inc. (OTCPK: FPMI) entered into a nonbinding letter of intent to acquire Ground Fluor Pharmaceuticals, Inc.
FluoroPharma Medical, Inc. Enters into Development and Commercialization Agreement with Sinotau USA Inc. for China and Canada
Fluoropharma Medical Inc. Accepts First Comparative Data from it's Phase II Trial of CardioPET in Subjects with High Likelihood of Coronary Artery Disease
FluoroPharma Medical, Inc. Auditor Raises 'Going Concern' Doubt
FluoroPharma Medical, Inc. announced that it expects to receive $1 million in funding
FluoroPharma Medical, Inc. Announces Resignation of Andrew H. Sassine as Member of the Board of Directors
FluoroPharma Medical, Inc. Announces Management Appointments
FluoroPharma Medical, Inc. Announces Board Changes
FluoroPharma Medical Inc Appoints Dr. Thomas H. Tulip as President
FluoroPharma Medical, Inc. announced that it has received $2.78 million in funding
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers FPMI
  4. Nieuws FluoroPharma Medical, Inc.
  5. Andere talen